查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608950

萤光素酶检测市场：依检测法、按应用划分 - 2025-2030 年全球预测

Luciferase Assays Market by Method (Dual Reporter Assay, Flash Assay, Glow Assay), Application (Gene Expression, Metabolic Activity, Protein-Protein Interaction) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年萤光素酶检测市值为15亿美元，预计到2024年将达到16亿美元，复合年增长率为7.03%，到2030年将达到24.2亿美元。

萤光素酶测定是用于测量特定酶的存在或活性的生化测定，具有从基因表现研究到细胞活力评估的广泛应用。这些测定利用了萤光素酶的发光能力，并已成为世界各地实验室的重要工具。这种需求源于对生物过程敏感即时监测的需求，从而能够快速筛检化合物和途径，特别是在药物发现和药物开发中。应用范围广泛，涵盖製药、生物技术、学术和临床研究领域。最终用途包括医疗机构、实验室和诊断中心。

主要市场统计
基准年[2023] 15亿美元
预测年份 [2024] 16亿美元
预测年份 [2030] 24.2亿美元
复合年增长率（%） 7.03%

萤光素酶检测市场受到几个关键成长要素的影响，例如研发投资的增加、生物技术的创新以及需要先进诊断工具的慢性病盛行率的增加。最近的发展，例如讯号强度和稳定性提高的新型突变萤光素酶的开发，为市场参与者扩大其产品组合提供了重要机会。分析师建议利用与研究机构的合作，并投资于提高检测灵敏度和即时资料分析的技术。

然而，市场成长面临挑战，例如检测试剂套件和设备的高成本，以及与扭曲结果的背景发光干扰相关的潜在技术限制。必须透过研究具有成本效益的生产技术和改进检测设计来解决这些限制。此外，针对最终用户的高级检测应用的持续教育和培训计划可以加速市场渗透。

业务成长的创新领域包括开发可以同时评估多个生物参数的多重萤光素酶检测，以及与人工智慧主导的分析平台整合以提高解释的速度和准确性。最后，该市场的特点是技术进步速度快，需要持续的研发努力以保持竞争优势并满足个人化医疗和高通量筛检的新兴需求。

市场动态：揭示快速发展的萤光素酶检测市场的关键市场洞察

供需的动态交互作用正在改变萤光素酶检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大分子生物学和基因工程的应用
    • 开发即时定量可视化基因表现的技术
    • 扩大研究投资和政府支持
  • 市场限制因素
    • 产生发光需要分子氧
  • 市场机会
    • 饮料业微生物污染检查的扩展应用
    • 玩家之间的策略联盟
  • 市场挑战
    • 相关技术问题

波特的五力萤光素酶测定是驾驭市场的策略工具

波特的五力框架是了解萤光素酶测定市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解萤光素酶检测市场的外部影响

外部宏观环境因素在塑造萤光素酶检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解萤光素酶检测市场的竞争格局

萤光素酶检测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵萤光素酶检测市场供应商的绩效评估

FPNV定位矩阵是评估萤光素酶检测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了萤光素酶检测市场的成功之路

萤光素酶检测市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大分子生物学和基因工程的应用
      • 开发即时定量可视化基因表现的技术
      • 增加研究投入和政府支持
    • 抑制因素
      • 产生发光需要分子氧
    • 机会
      • 越来越多地用于饮料行业来检查微生物污染
      • 玩家之间的战略合作
    • 任务
      • 相关技术问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章萤光素酶检测市场：依方法

  • 双报告基因检测
  • 快速测定
  • 发光分析
  • 单一报告基因检测

第七章萤光素酶检测市场：依应用分类

  • 基因表现
  • 代谢活动
  • 蛋白质-蛋白质相互作用
  • 转译后修饰

第八章美洲萤光素酶检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区萤光素酶检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲萤光素酶检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AAT Bioquest, Inc.
  • Abcam PLC
  • Active Motif, Inc.
  • Biotium
  • GeneCopoeia, Inc.
  • Gold Biotechnology
  • Invivogen
  • Lonza Group AG
  • Merck KGaA
  • Molecular Devices, LLC
  • Novus Biologicals
  • OriGene Technologies, Inc.
  • OZ Biosciences
  • Perkin Elmer, Inc.
  • Promega Corporation
  • PromoCell GmbH
  • SwitchGear Genomics, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-0302D35AB53D

The Luciferase Assays Market was valued at USD 1.50 billion in 2023, expected to reach USD 1.60 billion in 2024, and is projected to grow at a CAGR of 7.03%, to USD 2.42 billion by 2030.

Luciferase assays are biochemical analyses used to measure the presence or activity of specific enzymes, with applications ranging from gene expression studies to cell viability assessments. These assays capitalize on the luciferase enzyme's capability to produce luminescence, making them an indispensable tool in research laboratories globally. Their necessity arises from the demand for sensitive, real-time monitoring of biological processes, especially in drug discovery and development, where they facilitate rapid screening of compounds and pathways. The application scope is broad, encompassing pharmaceutical, biotech, academic, and clinical research sectors. End-use extends to healthcare institutions, research labs, and diagnostic centers.

KEY MARKET STATISTICS
Base Year [2023] USD 1.50 billion
Estimated Year [2024] USD 1.60 billion
Forecast Year [2030] USD 2.42 billion
CAGR (%) 7.03%

The market for luciferase assays is influenced by several key growth factors including the rise in R&D investments, innovations in biotechnology, and the increasing prevalence of chronic diseases necessitating advanced diagnostic tools. Recent advancements, such as the development of new mutant luciferases that enhance signal strength and stability, present significant opportunities for market players to expand their product offerings. Analysts recommend capitalizing on collaborations with research institutions and investing in technology to enhance assay sensitivity and real-time data analytics.

However, market growth faces challenges such as high costs of assay kits and equipment, and potential technical limitations involving background luminescence interference which can skew results. Addressing these limitations through research into cost-effective production techniques and improved assay designs is essential. Furthermore, continuous education and training programs for end-users on advanced assay applications can drive market penetration.

Innovative areas poised for business growth include the development of multiplexed luciferase assays that can simultaneously assess multiple biological parameters, and integration with AI-driven analytics platforms to enhance interpretation speed and accuracy. Lastly, the market is characterized by fast-paced technological advances, necessitating ongoing investment in R&D to maintain competitive advantage and address emerging needs in personalized medicine and high-throughput screening.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Luciferase Assays Market

The Luciferase Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased application in molecular biology and genetic engineering
    • Technological development to permit the quantitative visualization of gene expression in real time
    • Growing investment in research and government support
  • Market Restraints
    • Necessity for molecular oxygen to generate luminescence
  • Market Opportunities
    • Growing uses in beverage industry to check microbial contamination
    • Strategic collaboration between players
  • Market Challenges
    • Associated technical issues

Porter's Five Forces: A Strategic Tool for Navigating the Luciferase Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Luciferase Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Luciferase Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Luciferase Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Luciferase Assays Market

A detailed market share analysis in the Luciferase Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Luciferase Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Luciferase Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Luciferase Assays Market

A strategic analysis of the Luciferase Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Luciferase Assays Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Abcam PLC, Active Motif, Inc., Biotium, GeneCopoeia, Inc., Gold Biotechnology, Invivogen, Lonza Group AG, Merck KGaA, Molecular Devices, LLC, Novus Biologicals, OriGene Technologies, Inc., OZ Biosciences, Perkin Elmer, Inc., Promega Corporation, PromoCell GmbH, SwitchGear Genomics, Inc., Takara Bio Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Luciferase Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across Dual Reporter Assay, Flash Assay, Glow Assay, and Single Reporter Assay.
  • Based on Application, market is studied across Gene Expression, Metabolic Activity, Protein-Protein Interaction, and Post-Translational Modification.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased application in molecular biology and genetic engineering
      • 5.1.1.2. Technological development to permit the quantitative visualization of gene expression in real time
      • 5.1.1.3. Growing investment in research and government support
    • 5.1.2. Restraints
      • 5.1.2.1. Necessity for molecular oxygen to generate luminescence
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing uses in beverage industry to check microbial contamination
      • 5.1.3.2. Strategic collaboration between players
    • 5.1.4. Challenges
      • 5.1.4.1. Associated technical issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Luciferase Assays Market, by Method

  • 6.1. Introduction
  • 6.2. Dual Reporter Assay
  • 6.3. Flash Assay
  • 6.4. Glow Assay
  • 6.5. Single Reporter Assay

7. Luciferase Assays Market, by Application

  • 7.1. Introduction
  • 7.2. Gene Expression
  • 7.3. Metabolic Activity
  • 7.4. Protein-Protein Interaction
  • 7.5. Post-Translational Modification

8. Americas Luciferase Assays Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Luciferase Assays Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Luciferase Assays Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AAT Bioquest, Inc.
  • 2. Abcam PLC
  • 3. Active Motif, Inc.
  • 4. Biotium
  • 5. GeneCopoeia, Inc.
  • 6. Gold Biotechnology
  • 7. Invivogen
  • 8. Lonza Group AG
  • 9. Merck KGaA
  • 10. Molecular Devices, LLC
  • 11. Novus Biologicals
  • 12. OriGene Technologies, Inc.
  • 13. OZ Biosciences
  • 14. Perkin Elmer, Inc.
  • 15. Promega Corporation
  • 16. PromoCell GmbH
  • 17. SwitchGear Genomics, Inc.
  • 18. Takara Bio Inc.
  • 19. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. LUCIFERASE ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. LUCIFERASE ASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. LUCIFERASE ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. LUCIFERASE ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LUCIFERASE ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LUCIFERASE ASSAYS MARKET DYNAMICS
  • TABLE 7. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY DUAL REPORTER ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY FLASH ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY GLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY SINGLE REPORTER ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY GENE EХPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METABOLIC ACTIVITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY POST-TRANSLATIONAL MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. LUCIFERASE ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. LUCIFERASE ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023